NEO

NEO NeoGenomics, Inc.

Stock · NasdaqCM · United States · Healthcare · US64049M2098

NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by NeoGenomics, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.

Price 16.84 USD +2.12%

52-week range 7.07 – 20.15

Dividend yield—

Market cap2.2B

NowoTrade score 19 Grade A

Price history

Daily prices in USD.

Updated 07 Nov 2026 09:24. Information, not advice.

Results

Next results 16 Feb 2027 in 101 days · 16:00 · estimate 0.06

Last results 0.07 vs 0.06 estimated 28 Oct 2026 · Beat +26.2%

Beat the estimate 12 of 12 0 missed · 0 in line · 12 beats in a row

Average surprise +269.9% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

Estimate Reported: beat Reported: miss In line

Quarterly results

Date	EPS estimate	EPS reported	Surprise	Result
16 Feb 2027 16:00	0.06	—	—	Upcoming
28 Oct 2026 16:00	0.06	0.07	+26.2%	Beat
28 Jul 2026 16:00	0.03	0.05	+48.6%	Beat
28 Apr 2026 16:00	—	0.01	+800.9%	Beat
17 Feb 2026 07:00	0.04	0.06	+50.0%	Beat
28 Oct 2025 07:00	0.02	0.03	+25.8%	Beat
29 Jul 2025 07:00	0.02	0.03	+21.9%	Beat
29 Apr 2025 07:00	-0.01	—	+100.0%	—
18 Feb 2025 07:00	0.03	0.04	+40.0%	Beat
05 Nov 2024 07:00	0.01	0.05	+500.2%	Beat
29 Jul 2024 16:00	—	0.03	+1,398.7%	Beat
30 Apr 2024 07:00	-0.03	-0.02	+41.5%	Beat
20 Feb 2024 16:00	-0.03	0.03	+212.5%	Beat
06 Nov 2023 16:00	-0.08	-0.02	+72.0%	Beat
08 Aug 2023 07:00	-0.11	-0.05	+56.1%	Beat
09 May 2023 16:00	-0.15	-0.09	+40.6%	Beat
23 Feb 2023 07:00	-0.16	-0.06	+63.6%	Beat
08 Nov 2022 07:00	-0.21	-0.14	+32.1%	Beat
09 Aug 2022 07:00	-0.23	-0.16	+29.0%	Beat
27 Apr 2022 07:00	-0.24	-0.20	+16.7%	Beat
23 Feb 2022 07:00	-0.15	-0.14	+3.8%	Beat
04 Nov 2021 07:00	-0.09	-0.08	+6.8%	Beat
06 Aug 2021 07:00	-0.06	-0.01	+84.2%	Beat
05 May 2021 07:00	0.01	-0.04	-540.0%	Miss
24 Feb 2021 07:00	0.06	0.14	+133.3%	Beat
27 Oct 2020 08:00	0.04	0.06	+54.3%	Beat
28 Jul 2020 08:00	-0.10	-0.04	+61.5%	Beat
28 Apr 2020 08:00	0.02	-0.02	-200.0%	Miss
27 Feb 2020 13:00	0.06	0.10	+55.1%	Beat
29 Oct 2019 07:00	0.06	0.07	+16.7%	Beat
30 Jul 2019 13:00	0.06	0.07	+15.3%	Beat
30 Apr 2019 14:00	0.05	0.07	+45.8%	Beat
19 Feb 2019 07:00	0.04	0.06	+37.1%	Beat
30 Oct 2018 07:00	0.02	0.05	+140.9%	Beat
24 Jul 2018 07:00	0.04	0.05	+15.4%	Beat
01 May 2018 07:00	0.03	0.04	+29.0%	Beat
21 Feb 2018 07:00	0.04	0.05	+29.0%	Beat
25 Oct 2017 07:00	0.02	0.01	-43.3%	Miss
25 Jul 2017 07:00	0.03	0.04	+18.5%	Beat
26 Apr 2017 07:00	0.03	0.03	+6.7%	Beat
22 Feb 2017 07:00	0.03	0.05	+72.4%	Beat
26 Oct 2016 07:00	0.03	0.04	+44.0%	Beat
26 Jul 2016 07:00	0.03	0.04	+40.0%	Beat
27 Apr 2016 07:00	0.01	0.03	+200.0%	Beat
01 Mar 2016 10:00	0.02	0.02	+25.1%	Beat
29 Oct 2015 07:00	—	—	-100.0%	—
23 Jul 2015 07:00	-0.01	—	+100.0%	—
28 Apr 2015 07:00	-0.01	-0.01	0.0%	In line
24 Feb 2015 07:00	0.01	0.02	+100.0%	Beat
30 Oct 2014 07:00	-0.01	0.01	+200.0%	Beat

Annual results · USD

Year	Revenue	Change	Net income	Net margin	EPS	EPS change	Free cash flow
2025	727.3M	+10.1%	-108M	-14.9%	-0.84	-35.5%	-21.8M
2024	660.6M	+11.6%	-78.7M	-11.9%	-0.62	+11.4%	-34M
2023	591.6M	+16.1%	-88M	-14.9%	-0.70	+39.7%	-30.7M
2022	509.7M	—	-144.3M	-28.3%	-1.16	—	-96.9M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Day Week Month

Price history in USD, by day
Period	Opening price	High	Low	Closing price	Change	Volume
06 Nov 2026	16.85	16.93	16.12	16.84	+2.12%	1,314,000
05 Nov 2026	16.90	16.90	15.90	16.49	-3.85%	2,105,300
04 Nov 2026	17.26	17.39	16.60	17.15	+1.90%	1,149,900
03 Nov 2026	16.65	17.34	16.57	16.83	+2.06%	1,810,100
02 Nov 2026	17.66	17.66	16.29	16.49	-5.12%	1,706,100
30 Oct 2026	17.95	18.15	17.09	17.38	-3.07%	1,464,100
29 Oct 2026	17.25	18.15	16.83	17.93	-0.33%	3,759,000
28 Oct 2026	17.30	18.03	17.25	17.99	+4.17%	2,577,300
27 Oct 2026	16.91	17.48	16.69	17.27	+3.48%	2,753,300
26 Oct 2026	16.62	17.00	16.61	16.69	+0.60%	1,302,400
23 Oct 2026	16.36	16.76	16.07	16.59	+1.22%	1,431,500
22 Oct 2026	16.89	17.17	16.13	16.39	-3.81%	2,463,400
21 Oct 2026	16.62	17.30	16.54	17.04	+2.53%	1,493,600
20 Oct 2026	16.55	16.92	16.39	16.62	+1.22%	1,103,000
19 Oct 2026	16.90	17.17	16.39	16.42	-1.38%	1,332,300
16 Oct 2026	17.24	17.45	16.44	16.65	-3.48%	2,308,900
15 Oct 2026	17.00	17.34	16.61	17.25	+2.19%	1,315,000
14 Oct 2026	16.49	17.25	16.45	16.88	+1.32%	1,615,900
13 Oct 2026	16.30	16.98	15.98	16.66	+2.84%	2,233,100
12 Oct 2026	16.35	16.35	15.86	16.20	-0.92%	1,183,600
09 Oct 2026	16.02	16.66	16.00	16.35	+2.06%	1,385,300
08 Oct 2026	15.72	16.09	15.41	16.02	+0.31%	3,518,300
07 Oct 2026	16.36	16.64	15.88	15.97	-3.27%	3,191,900
06 Oct 2026	20.00	20.15	16.47	16.51	-13.70%	5,097,500
05 Oct 2026	18.48	19.13	18.28	19.13	+3.57%	2,048,900

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Did Narrower Quarterly Loss Just Shift NeoGenomics Stock Investment Narrative? (opens in a new tab) 06 Nov 2026 02:16
NEO Q3 deep dive: product mix shift and margin expansion drive robust oncology testing growth (opens in a new tab) 03 Nov 2026 07:57
5 revealing analyst questions from NeoGenomics’s Q3 earnings call (opens in a new tab) 31 Oct 2026 19:47

Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close: 16.49 USD
Market cap: 2.2B
Exchange: NasdaqCM
Country: United States
Sector: Healthcare
Industry: Diagnostics & Research
Currency: USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the score	Points	Why
Business growth Yearly growth of revenue and of earnings per share.	21.0 / 25	Revenue growth of 12.6% a year
Quality Return on equity, net margin and how stable the margins are.	0.0 / 25	ROE of -4%
Financial strength Net debt against operating earnings, interest cover and free cash flow.	3.6 / 20	Net debt is 13.6× EBITDA Free cash flow yield of 0.2%
Valuation Free cash flow yield and the P/E against its sector.	0.3 / 15	Forward P/E 53.5: it is expected to earn money
Analysts How far the analysts' average target is from today's price.	10.0 / 10	Analysts' target is +39% from the price

Score capped at 50: three or more warnings
Heavy debt: net debt is 13.6× EBITDA
Thin interest cover: operating profit is only -23.5× the interest
The last full year was a loss

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 18 points off.

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.

Figures

Valuation
Figure	Value	Reading	Sector median
P/E (forward)	53.54×	Weak	14.98×
Price / book	2.72×	Fair	3.94×
Price / sales	2.77×	Fair	3.37×
EV / EBITDA	107.35×	Weak	12.96×
Free cash flow yield	0.2%	Weak	2.6%

Quality
Figure	Value	Reading	Sector median
Gross margin	44.8%	Good	59.2%
Operating margin	-3.8%	Weak	7.4%
Net margin	-4.1%	Weak	3.4%
Return on equity	-3.9%	Weak	5.7%
Return on assets	-2%	Weak	3.6%

Growth
Figure	Value	Reading	Sector median
Revenue growth / year	12.6%	Good	10.8%

Financial health
Figure	Value	Reading	Sector median
Debt / equity	0.56×	Good	0.46×
Net debt / EBITDA	13.61×	Weak	1.5×
Interest cover	-23.48×	Weak	3.26×
Current ratio	3.53×	Good	2.35×

Dividends
Figure	Value	Reading	Sector median
Payout of earnings	0%	Weak	0%

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Follow NEO and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in